Silex Systems Limited · ASX:SLX
Silex Systems — Investor Presentation (May 2020)
33 slides from Silex Systems's investor presentation, May 4, 2020
Slide 1: Investor Presentation
For personal use only Investor Presentation 4 May 2020 Silex Systems Limited (Silex) (ASX: SLX) (OTCQX: SILXY) has updated its Investor Presentation (attached). The presentation is intended for shareholders and other stakeholders on the Company’s ongoing activities and covers a number of recent deve
Slide 2: Forward Looking Statements and Business Risks
Forward Looking Statements and Business Risks: Silex Systems Limited (Silex) is a research and development company whose primary asset is the SILEX laser enrichment technology, originally developed at the Company’s technology facility in Sydney, Australia. The SILEX technology was licensed exclusive
Slide 3: Silex Systems Limited Investor Presentation
For personal use only Silex Systems Limited Investor Presentation (ASX: SLX) (OTCQX: SILXY) Dr Michael Goldsworthy CEO/Managing Director May 2020 1
Slide 4: Forward Looking Statements
Forward Looking Statements For personal use only Silex Systems Limited (Silex) is a research and development company whose primary asset is the SILEX laser enrichment technology, originally developed at the Company’s technology facility in Sydney, Australia. The SILEX technology was licensed exclusi
Slide 5: Disclaimer
Disclaimer For personal use only Silex Systems Limited (Silex) has prepared this presentation based on information available to it. The information in this presentation does not purport to be a complete description of Silex and/or its business activities. Except as required by law, no representation
Slide 6: Silex is a platform technology company
For personal use only Silex is a platform technology company focused on the commercialisation of our innovative SILEX laser enrichment technology across multiple markets 4
Slide 7: The Silex Business Case
The Silex Business Case For personal use only Two technologies being commercialised: 1) SILEX Laser Isotope Separation Technology 2) cREO™ Advanced Semiconductor Material Technology Three commercial applications under development: 1) SILEX Uranium Enrichment Project with US-based Global Laser Enrich
Slide 8: Target Industry Sectors
Target Industry Sectors For personal use only Target industry sectors are significant markets Nuclear Fuel Quantum 5G Front End Uranium market Computing Handset components ~ US$7bn (est. 2022) Potential market ~US$3bn (by 2023) Enrichment market ~ US$1bn (by 2025) (Note: cREO™ based components likel
Slide 9: Our Strategy
Our Strategy For personal use only ❑ Secure the commercialisation path for our core asset - the SILEX technology - in the primary application of uranium enrichment ❑ Preserve the Paducah commercial opportunity and the underpinning 2016 Agreement between GLE and the US Department of Energy in order t
Slide 10: Highlights of the Past Year
Highlights of the Past Year For personal use only ❑ Silex and Cameco signed a binding agreement in December 2019 for the restructure of SILEX technology licensee – GLE, involving the joint purchase of GE-Hitachi’s 76% interest in GLE ❑ Subject to obtaining US government approvals, completion of the
Slide 11: SILEX Laser Uranium Enrichment Technology
For personal use only SILEX Laser Uranium Enrichment Technology 9
Slide 12: Enrichment Technology Overview
Enrichment Technology Overview For personal use only SILEX - third generation enrichment technology • SILEX - Separation of Isotopes by Laser EXcitation • Highly selective laser excitation of 235UF6 drives efficient isotope separation • High enrichment efficiency expected to make SILEX technology ve
Slide 13: SILEX and Nuclear Fuel Production
SILEX and Nuclear Fuel Production For personal use only • The SILEX technology can be utilized to produce: i) natural grade uranium via re-enrichment of tails inventories (Paducah project) ii) enriched uranium for use as fuel in nuclear power reactors (including HALEU) • Uranium production (~45%) an
Slide 14: SILEX Technology Commercialisation Program
SILEX Technology Commercialisation Program For personal use only • Commercialisation program ~ US$500 million invested to date • Phase I - Technology Validation: completed in 2013 at GLE’s Test Loop Facility in the US • Phase II - Engineering and Economic Validation: includes demonstration of full-s
Slide 15: The GLE Restructure
For personal use only The GLE Restructure 13
Slide 16: The GLE Restructure
The GLE Restructure For personal use only • Silex to acquire a 51% interest in GLE – Cameco to increase their interest from 24% to 49% • No upfront consideration – deferred annual purchase payments (4 x US$5 million) triggered after 1st year GLE generates US$50 million in revenues • A Site Lease wil
Slide 17: The SILEX Technology License Agreement and the Paducah Opportunity
For personal use only The SILEX Technology License Agreement and the Paducah Opportunity 15
Slide 18: SILEX License Agreement Overview
SILEX License Agreement Overview For personal use only Technology License Agreement with GLE: • Exclusive worldwide commercialisation and license agreement for the SILEX laser uranium enrichment technology – signed in 2006 • Technology validation milestone May 2013 – triggered US$15 million payment
Slide 19: The Paducah Opportunity – a 'Tier 1' Uranium Project
The Paducah Opportunity – a ‘Tier 1’ Uranium Project For personal use only • Sales Agreement between GLE and DOE signed in November 2016 – for the sale of DOE tails inventories to GLE - underpins the Paducah Laser Enrichment Project • Re-enrichment of DOE tails inventories equivalent to a large, low
Slide 20: Nuclear Power Growth and Market Outlook
For personal use only Nuclear Power Growth and Market Outlook 18
Slide 21: Benefits of Nuclear Power
Benefits of Nuclear Power For personal use only ❑ Proven, robust and reliable base-load generation ❑ Largest source of carbon-free power in the US, EU and developing economies - key to climate change mitigation ❑ Affordable and reliable electricity to a growing global population - low generation cos
Slide 22: The Future - Small Modular Reactors (SMRs)
The Future - Small Modular Reactors (SMRs) For personal use only Next generation of nuclear reactors may offer significant advantages over large conventional reactors ❑ Modular, smaller size (50 MWe to 300 MWe) allows flexibility in deployment ❑ Likely to be competitive with distributed generation s
Slide 23: US Nuclear Industry Review
US Nuclear Industry Review For personal use only ❑ Growing concerns the US has fallen behind China, Russia and other state-owned enterprises in nuclear technology ❑ US nuclear fuel supply is currently dominated by foreign imports for uranium, and foreign enrichment providers ❑ Nuclear Fuel Working G
Slide 24: Uranium Market Outlook
Uranium Market Outlook For personal use only Uranium Supply and Demand Forecast Source: UxC Uranium Market Outlook, Q1 2020 Year • Uranium supplies will remain excess to demand, under the mid-case scenario, until around 2027 • Secondary uranium supplies include production from underfeeding and tails
Slide 25: Uranium Price – Early Signs of Term Price Recovery?
Uranium Price – Early Signs of Term Price Recovery? For personal use only Uranium Mid Long-Term Base Price Forecast Year Source: UxC Uranium Market Outlook, Q1 2020 • UxC forecast the mid-case uranium price recovering to over US$50/lb from around 2025 • Recovery of the uranium market price is key to
Slide 26: Zero-Spin Silicon Project for Quantum Computing
For personal use only Zero-Spin Silicon Project for Quantum Computing 24
Slide 27: ZS-Si: Silicon Enrichment Project for Quantum Computing
ZS-Si : Silicon Enrichment Project for Quantum Computing For personal use only ❑ Stable isotope program underway to utilise our significant Laser Isotope Separation (LIS) expertise for semiconductor and medical applications ❑ Zero-Spin Silicon (ZS-Si) is a unique form of isotopically enriched silico
Slide 28: Translucent Inc cREO Technology
For personal use only Translucent Inc cREO™ Technology 26
Slide 29: The Translucent – IQE Agreement
The Translucent – IQE Agreement For personal use only ❑ Silex subsidiary Translucent’s ‘Rare Earth Oxide’ (cREO™) technology purchased by UK-based IQE in 2018 with payment of US$5 million in IQE shares ❑ IQE is the global leader in the design and manufacture of advanced semiconductor wafer products
Slide 30: cREO - IQE Development Program
cREO™ - IQE Development Program For personal use only ❑ cREO™ technology commercialisation program being conducted at IQE’s Greensboro, US manufacturing facility ❑ Significant investment by IQE to progress development of cREO™ advanced semiconductor material technologies ❑ Good progress has been mad
Slide 31: Summary
For personal use only Summary 29
Slide 32: Summary
Summary For personal use only • Current focus is on finalisation of the GLE restructure and continuation of the SILEX technology commercialisation project at GLE’s facility in the US and Silex’s facility in Sydney • Successful completion of the GLE restructure, subject to US government approvals, wi
Slide 33: Thank you
For personal use only Thank you 31